Article
Diagnosis and Classification of Myelodysplastic Syndromes with Mutated TP53.
Clinics in laboratory medicine - 1 Dec 2023
Siddon Alexa J, Weinberg Olga K
Abstract excerpt
The genetic underpinnings of myeloid neoplasms are becoming increasingly well understood. The accessibility to sequencing technology, in particular next-generation sequencing (NGS), has highlighted the importance of gene mutations in myelodysplastic syndromes (MDS) in conjunction with traditional cytogenetics. With the relatively recent influx of molecular information to complement known cytogenetic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
